Unichem Laboratories share news and announcements
NSE: UNICHEMLABBSE: 506690Pharmaceuticals & BiotechnologySmall Cap
Last close ₹472.95down ₹14.80 (3.03%)BSE ₹471.95
Share price at the NSE close on 23 Oct 2026. Previous close ₹487.75.
52-week range of traded prices to 23 Oct 2026
₹278.20Low, 30 Mar 2026₹687.20High, 9 Jul 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹3,330 Cr1,036th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 11 Aug 2026
- 10.9
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹205 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 33.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 22 May 2026
- 1.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- 11.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹205 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 3.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 3.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 22 May 2026
- 0.17
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 40,08440.7% delivered
Unichem Laboratories share news and announcements
717 announcements, routine notices left out, newest first. Page 12 of 15.
Oct 2013
10 Oct · Board meeting
Inter-alia, to consider and take on record the Un-audited Accounts for the year ended September 30, 2013.8 Oct · Business
Board has approved allotment of 16,375 equity shares through circular resolution on September 19, 2013 pursuant to exercise of the stock options by the eligible employees under the Employee Stock Option Scheme 2008 of the Company.
Aug 2013
Jul 2013
22 Jul · Disclosure of Voting Pattern - Clause 35A
11 Jul · Business
Board has approved allotment of 11,250 equity shares through circular resolution on July 06, 2013 pursuant to exercise of the stock options by the eligible employees under the Employee Stock Option Scheme 2008 of the Company.8 Jul · Board meeting
Inter alia, to consider and take on record the Un-audited Financial Results of the Company for the Quarter ended June 30, 2013.1 Jul · Board meeting
Board of directors in its meeting held on June 29, 2013, allotted and issued 88,788 equity shares of Rs. 2/- each pursuant to exercise of the stock options by the eligible employees under the Employee Stock Option Scheme 2008 of the Company.
May 2013
13 May · Dividend
Board of Directors of the Company at its meeting held on May 11, 2013 has recommended Dividend of Rs. 4.50 (225%) per equity share of Rs. 2/- each, for the year ended March 31, 2013, subject to approval of Shareholders at ensuring Annual General Meeting.13 May · Board meeting
Board of Directors of the Company at its meeting held on May 11, 2013, inter alia, has considered the following:(1) Allotted and issued 13,750 equity shares of Rs. 2/- each pursuant to the exercise of the Stock Option Scheme - 2008 of the Company.13 May · Meeting
Company has decided to close the Register of Members and Share Transfer Books of the Company from July 15, 2013 to July 19, 2013 (both days inclusive) for the purpose of Dividend and Annual General Meeting of the Company to be held on July 19, 2013.
Apr 2013
Mar 2013
20 Mar · Board meeting
Board of Directors in its meeting held on March 20, 2013, allotted and issued 8,312 equity shares of Rs. 2/- each pursuant to exercise of the stock options by the eligible employees under the Employee Stock option Scheme 2004 and Employee Stock option Scheme 2008 of the Company.
Feb 2013
Jan 2013
8 Jan · Board meeting
Inter-alia, to consider and take on record the Un-audited Financial Results of the Company for the quarter ended December 31, 2012.
Nov 2012
Oct 2012
9 Oct · Board meeting
Inter-alia to consider and take on record the Un-audited Financial Results of the Company for the Quarter ended September 30, 2012.
Sep 2012
Aug 2012
13 Aug · Meeting
Board of Directors of the Company at its meeting held on August 13, 2012 has decided to convene the Annual General Meeting of the Company on September 27, 2012. Further the Company has decided to close the Register of Members and Share Transfer Books of the Company from September 17, 2012 to September 21, 2012 (both days inclusive), for the purpose of Dividend and Annual General Meeting.13 Aug · Management
Mr. Bhagwat S. Dhingra has been appointed as Chief Executive- Domestic Pharma, in place of Mr. Harcharan Singh, with effect from August 06, 2012. He shall report to Dr. Prakash A. Mody, Chairman & Managing Director. Mr. Harcharan Singh will be in an Advisory role for some time and thereafter will be looking for entrepreneurial opportunities.11 Aug · Dividend
Board of Directors of the Company at its meeting held on August 11, 2012 has recommended Dividend of Rs. 3.00 (150%) per equity share of Rs. 2/- each, for the year ended March 31, 2012.11 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 11, 2012 ,inter alia, considered the following:(1) Allotted and issued 28,293,990 equity shares of Rs. 2/- each to shareholders of AVM Capital Services Private Limited, Chevy Capital Services Private Limited, PM Capital Services Private Limited, Pranit Trading Private Limited and Viramrut Trading Private Limited ("Transferor Companies") pursuant to its amalgamation with Unichem Laboratories Limited ("Transferee Company") vide Hon'ble High Court of Bombay Order dated July 12, 2012.(2)Allotted and issued 1,16,125 equity shares of Rs. 2/- each pursuant to the exercise of the stock options by eligible Independent Directors and employees under the Employee Stock Option Scheme - 2008 of the Company.6 Aug · Board meeting
Inter-alia, to consider and take on record the Un-audited Financial Results of the Company for the Quarter ended June 30, 2012, Audited Accounts for the year ended March 31, 2012 and to recommend Dividend on equity shares for the Financial Year 2011-12, if any.
Jul 2012
18 Jul · Business
Vide letter dated July 17, 2012 that the Hon'ble High Court Bombay vide its order dated July 12, 2012 approved the Scheme of Arrangement between AVM Capital Services Private Limited ('ACSPL') and Chevy Capital Services Private Limited ('CCSPL') and PM Capital Services Private Limited ('PCSPL') and Pranit Trading Private Limited ('PTPL') and Viramrut Trading Private Limited ('VTPL') and Unichem Laboratories Limited ('ULL') and their respective shareholders under Section 391 to 394 read with Sections 80, 100 to 103 and any other applicable provisions of the Companies Act, 1956 ('Scheme' or 'the Scheme').
May 2012
12 May · Business
Board of Directors in its meeting held on May 12, 2012 inter alia allotted and issued 10,500 equity shares of Rs. 2/- each pursuant to the exercise of the stock options by the eligible employees under the Employee Stock Option Scheme - 2008 of the Company.3 May · Board meeting
Interalia to consider and adopt Unaudited financial results for the quarter and year ended March 31,2012.
Jan 2012
23 Jan · Board meeting
Board of Directors in its meeting held on January 21, 2012 inter alia allotted and issued 2,500 equity shares of Rs. 2/- each pursuant to the exercise of the stock options by the eligible employees under the Employee Stock Option Scheme - 2008 of the Company.10 Jan · Board meeting
Inter-alia, to consider and take on record the Un-audited Financial Results of the Company for the Quarter ended December 31, 2011.
Dec 2011
Nov 2011
4 Nov · Outcome of meeting
In accordance with the directions of the Hon'ble High Court of Bombay in Company Summon for Direction No.603 of 2011, meeting of Equity Shareholders of the Company to approve the Scheme of Arrangement between AVM Capital Services Private Limited and Chevy Capital Services Private Limited and PM Capital Services Private Limited and Pranit Trading Private Limited and Viramrut Trading Private Limited and Unichem Laboratories Limited was convened and held on November 03, 2011. Further at the said meeting the equity shareholders have approved the Scheme of Arrangement with overwhelming majority.